Inventor
DILLON STACEY R
US39 patents
⚠️ This page may combine multiple inventors who share the name “DILLON STACEY R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZYMOGENETICS INC
30 patentsUS6686178B2Feb 3, 2004
Cytokine zalpha11 ligand polynucleotides
ZYMOGENETICS INC113 citations99
US6605272B2Aug 12, 2003
Methods of using zalpha11 ligand
ZYMOGENETICS INC117 citations99
US6307024B1Oct 23, 2001
Cytokine zalpha11 Ligand
ZYMOGENETICS INC232 citations99
US7494804B2Feb 24, 2009
Polynucleotide encoding cytokine receptor zcytor17 multimer
ZYMOGENETICS INC66 citations98
US7473765B2Jan 6, 2009
Cytokine zalpha11 ligand
ZYMOGENETICS INC29 citations96
US7491800B2Feb 17, 2009
Cytokine zalpha11 ligand fusion proteins
ZYMOGENETICS INC9 citations93
US10227415B2Mar 12, 2019
Methods of producing a zcytor17 heterodimeric cytokine receptor
ZYMOGENETICS INC12 citations92
US7537761B2May 26, 2009
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
ZYMOGENETICS INC18 citations92
US7393684B2Jul 1, 2008
Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies
ZYMOGENETICS INC25 citations92
US8647866B2Feb 11, 2014
ZCYTOR17 heterodimeric cytokine receptor polynucleotides
ZYMOGENETICS INC10 citations84
USRE41129EFeb 16, 2010
Cytokine zalpha11 ligand polynucleotides
ZYMOGENETICS INC7 citations82
US7611699B2Nov 3, 2009
Methods of using cytokine zalpha11 ligand
ZYMOGENETICS INC6 citations82
US7572892B2Aug 11, 2009
Cytokine zalpha11 ligand fusion proteins
ZYMOGENETICS INC6 citations82
US9725506B2Aug 8, 2017
Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus
ZYMOGENETICS INC11 citations81
US7998468B2Aug 16, 2011
Cytokine zalpha11 ligand antibodies
ZYMOGENETICS INC2 citations74
US7829075B2Nov 9, 2010
Method for expanding hematopoietic cells using cytokine zalpha11 ligand
ZYMOGENETICS INC2 citations74
US7626002B2Dec 1, 2009
Cytokine zalpha11 ligand antibodies
ZYMOGENETICS INC2 citations74
US7569670B2Aug 4, 2009
Cytokine zalpha11 ligand fusion proteins
ZYMOGENETICS INC4 citations74
US8383775B2Feb 26, 2013
Cytokine zalpha11 ligand
ZYMOGENETICS INC1 citations63
US8017343B2Sep 13, 2011
Cytokine zalpha11 ligand antibodies and methods of use
ZYMOGENETICS INC0 citations63
US7592425B2Sep 22, 2009
Cytokine zalpha11 ligand fusion proteins
ZYMOGENETICS INC0 citations63
US7579441B2Aug 25, 2009
Cytokine zalpha11 ligand fusion proteins
ZYMOGENETICS INC0 citations63
US7507580B2Mar 24, 2009
Ztnfr14, a tumor necrosis factor receptor
ZYMOGENETICS INC3 citations63
US7871616B2Jan 18, 2011
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
ZYMOGENETICS INC1 citations62
US8361470B2Jan 29, 2013
Methods of treatment using anti-human IL-21 monoclonal antibodies
ZYMOGENETICS INC1 citations61
US7883700B2Feb 8, 2011
Anti-human IL-21 monoclonal antibodies
ZYMOGENETICS INC3 citations61
US9738700B2Aug 22, 2017
ZCYTOR17 heterodimeric cytokine receptor
ZYMOGENETICS INC0 citations52
US9212213B2Dec 15, 2015
ZCYTOR17 heterodimeric cytokine receptor
ZYMOGENETICS INC0 citations52
USRE48370EDec 29, 2020
Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus
ZYMOGENETICS INC0 citations49
US9146242B2Sep 29, 2015
Levels of BLyS/APRIL heterotrimers in serum and use in diagnostic methods
ZYMOGENETICS INC0 citations31
XU WENFENG
4 patentsUS8163286B2Apr 24, 2012
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
XU WENFENG2 citations61
US8124088B2Feb 28, 2012
Methods of treatment using anti-IL-22RA antibodies
XU WENFENG3 citations61
US8536309B2Sep 17, 2013
Methods of producing anti-IL-22RA antibodies
XU WENFENG0 citations51
US8907068B2Dec 9, 2014
Anti-IL-20 antibodies and binding partners and methods of using in inflammation
XU WENFENG0 citations49